TE_38409
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1PBa1_5end |
|---|---|
| TE superfamily | L1 |
| TE order | LINE |
| Gene | ENSG00000233928 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 361.80 |
| Counts of samples | TCGA_tumor:641; TCGA_normal:1; GTEx:0 |
| TSS | chrX(+):33742020 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38409.1 | ENSG00000233928 | Annoated | Non-coding | Non-coding | chrX(+):33742021,33742134,33853615,33853715,33942015,33942035 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
